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Vertebral compression fractures after spine irradiation 
using conventional fractionation in patients with 
metastatic colorectal cancer
Woo Joong Rhee, MD, Kyung Hwan Kim, MD, Jee Suk Chang, MD,  
Hyun Ju Kim, MD, Seohee Choi, MD, Woong Sub Koom, MD
Department of Radiation Oncology, Yonsei Cancer Center, Yonsei University Health System, Seoul, Korea
Purpose: To evaluate the risk of vertebral compression fracture (VCF) after conventional radiotherapy (RT) for colorectal cancer 
(CRC) with spine metastasis and to identify risk factors for VCF in metastatic and non-metastatic irradiated spines.
Materials and Methods: We retrospectively reviewed 68 spinal segments in 16 patients who received conventional RT between 
2009 and 2012. Fracture was defined as a newly developed VCF or progression of an existing fracture. The target volume included 
all metastatic spinal segments and one additional non-metastatic vertebra adjacent to the tumor-involved spines.
Results: The median follow-up was 7.8 months. Among all 68 spinal segments, there were six fracture events (8.8%) including 
three new VCFs and three fracture progressions. Observed VCF rates in vertebral segments with prior irradiation or pre-existing 
compression fracture were 30.0% and 75.0% respectively, compared with 5.2% and 4.7% for segments without prior irradiation or 
pre-existing compression fracture, respectively (both p < 0.05). The 1-year fracture-free probability was 87.8% (95% CI, 78.2–97.4). 
On multivariate analysis, prior irradiation (HR, 7.30; 95% CI, 1.31–40.86) and pre-existing compression fracture (HR, 18.45; 95% CI, 
3.42–99.52) were independent risk factors for VCF.
Conclusion: The incidence of VCF following conventional RT to the spine is not particularly high, regardless of metastatic tumor 
involvement. Spines that received irradiation and/or have pre-existing compression fracture before RT have an increased risk of VCF 
and require close observation.
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Introduction
Colorectal cancer (CRC) is the third most commonly diagnosed 
cancer in males and the second in females, with over 1.2 
million estimated new cases worldwide per year [1]. Among 
more than 2,500 CRC patients in Italy, approximately 10% 
had bone metastasis and spinal segments were the most 
common site of bone metastases, with an incidence of 65% 
[2]. Radiation therapy (RT) is thought to be an important 
palliative treatment modality for spine metastasis. Although 
conventional RT is traditionally the standard of care 
for palliative treatment of spine metastasis [3-6], spine 
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stereotactic body radiation therapy (SBRT) is an emerging 
treatment option for patients with spine metastasis [7,8]. 
 With the increased use of SBRT, the occurrence of vertebral 
compression fractures (VCFs) after SBRT has become an 
important issue. Memorial Sloan-Kettering Cancer Center 
(MSKCC) reported the first data on VCFs, demonstrating that 
27 VCFs developed in a total of 71 spinal segments (39%) 
after SBRT [9]. The MD Anderson Cancer Center (MDACC) 
subsequently reported similar findings of 25 VCFs in 123 spinal 
segments (20%) treated with SBRT [10]. 
 The Spine Oncology Study Group (SOSG) introduced the 
Spinal Instability Neoplastic Score (SINS) criteria to predict 
the stability of metastatic vertebral segments [11]. The SINS 
criteria consist of six components: location, pain, bone lesion, 
radiographic spinal alignment, vertebral body collapse, and 
posterolateral involvement of spinal elements. SINS class is 
determined by the sum of the component scores, and ranges 
from 0 to 18. A score of 0 to 6 denotes class 1 (stable), 7 to 12 
denotes class 2 (potentially unstable), and 13 to 18 denotes 
class 3 (unstable). Researchers at the University of Toronto 
evaluated not only the incidence and risk factors of VCF after 
SBRT, but also the validity of SINS criteria [12]. However, there 
are no clear data on VCF development after conventional RT, 
which is still commonly used in real practice.
 In this study, we aimed to determine the incidence of 
VCF after conventional RT for CRC with spine metastasis. 
In addition, we investigated the risk factors for VCF in both 
metastatic and non-metastatic irradiated spinal segments. 
Lastly, we evaluated the role of SINS criteria as an additional 
predictive factor for VCF in metastatic irradiated spinal 
segments.
Materials and Methods
1. Patient selection
We retrospectively reviewed 98 spinal segments in 24 patients 
who were treated with conventional RT between March 2009 
and October 2012. All patients were diagnosed with CRC with 
spine metastasis and had more than 6 months of clinical 
follow-up. Spinal segments that had a fracture event within 
the 6-month follow-up period after RT were also included in 
our study cohort. This study included not only the metastatic 
vertebra, but also all non-metastatic vertebra involved in the 
RT volume even if they had pre-existing fractures. Patients 
with a double primary cancer, a diagnosis of osteoporosis, 
and those who were receiving bisphosphonate therapy were 
excluded. Spinal segments that had previously undergone 
surgery or a procedure related to vertebral stability, or were 
treated with SBRT, were also excluded. After patient selection, 
our final cohort consisted of 68 spinal segments in 16 patients. 
2. Treatment and evaluation
All patients were treated with conventional RT. The target 
volume included all metastatic spinal segments and one 
additional level of non-metastatic vertebra adjacent to the 
tumor-involved spines. We evaluated the latest computed 
tomography (CT) and/or magnetic resonance image (MRI) scans 
that were taken before planning to determine target volume. 
The total dose and fractions were determined depending 
on the patient’s performance status and presence of pre-
existing fracture and/or irradiation history. Patients with good 
performance status were treated with 30 Gy in 10 fractions 
(n = 52 segments) and patients with poor performance status 
received either 20 Gy in five fractions (n = 5) or 8 Gy in one 
fraction (n = 3). For patients with pre-existing fracture or a 
previously irradiated spine in the RT field, a lower fraction dose 
was used as follows: 25 Gy in 10 fractions (n = 5), 30 Gy in 25 
fractions (n = 2), and 45 Gy in 25 fractions (n = 1). 
 Pretreatment evaluation of vertebral status was performed 
by planning CT and diagnostic CT/MRI studies. A VCF was 
defined as the development of a new VCF or fracture 
progression in a previously fractured vertebra after irradiation. 
Fracture progression was defined as more than a 20% 
reduction in vertebral body height; the same definition was 
used in MDACC study [10]. In addition, we used CT images to 
distinguish the type of bone lesion (lytic, blastic, or mixed). 
MR images were examined to determine paraspinal extension, 
vertebral body collapse, and posterior element involvement. 
Both CT and MR images were used to determine the degree 
and presence of vertebral compression fracture and spine 
alignment. Development of VCF was identified by follow-up 
imaging studies (CT or MRI), which were performed at 2- to 
4-month intervals. Every vertebral segment with a metastatic 
lesion was scored according to SINS criteria. We also evaluated 
the primary tumor pathology, body mass index (BMI), total 
dose, fractional dose, and use of chemotherapy. Information 
on general patient characteristics (i.e., age, sex) and presence 
of pain was collected from medical records. 
3. Statistical analysis
All factors were compared by the Fisher exact test. In addition, 
these factors were also analyzed with logistic regression 
analysis. Time-to-event data were calculated in months 
from the start date of RT to the date of the event or last 
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imaging follow-up if there was no fracture event. Fracture-
free-probability (FFP) was analyzed using the Kaplan-Meier 
estimation method. The log-rank test was used for univariate 
analysis to compare FFP for each potential risk factor. The 
multivariate Cox proportional hazards regression model 
was used to determine the associated effect of potential 
risk factors that were identified as significant factors on 
univariate analysis. For all analyses, statistical significance was 
determined by a p-value <0.05. 
Results
The median follow-up duration was 7.8 months (range, 4.9 
to 47.1 months). Among 68 spinal segments, there were six 
fracture events (8.8%) including three new VCFs and three 
fracture progressions. Patient and treatment characteristics 
are summarized in Table 1. The median age was 60 years and 
seven of the 16 patients were male. Among the total 68 spinal 
segments, 42 vertebral segments (61.8%) showed metastatic 
involvement, 10 (14.7%) had prior irradiation, and four (5.9%) 
had pre-existing fracture. 
 The observed VCF rates in vertebral segments with prior 
irradiation or pre-existing compression fracture were 30.0% 
and 75.0%, respectively, compared with 5.2% for those 
without prior irradiation history and 4.7% for those without 
pre-existing compression fracture (p < 0.037 and p < 0.002, 
respectively) (Table 2). The use of chemotherapy during RT 
and each chemotherapy regimen (data not shown on table) 
were not related with the development of VCF. After logistic 
regression analysis, pre-existing compression fracture (p = 
0.002) and prior irradiation (p = 0.028) were confirmed as 
risk factors for VCF. The 1-year FFP was 87.8% (Fig. 1A). The 
median time to VCF after RT was 5.65 months (range, 4.9 to 
8.9 months). In univariate analysis of risk factors for VCF, prior 
irradiation (p = 0.015), pre-existing compression fracture (p < 
0.001), fractional dose less than 3.0 Gy (p = 0.004), and total 
EQD2 less than 32 Gy (p = 0.006) were identified as significant 
factors (Fig. 1B, 1C). Multivariate analysis revealed prior 
irradiation (HR, 7.30; 95% CI, 1.31–40.86; p = 0.024) and pre-
existing compression fracture (HR, 18.45; 95% CI, 3.42–99.52; 
p = 0.001) as significant risk factors for VCF (Table 3). 
 Among the 42 metastatic spinal segments we observed 
five VCFs (11.9%), including two new VCFs and three fracture 
progressions (Table 4). The rate of VCF in vertebral segments 
with prior irradiation history was 33.3%, compared with 6.1% 
for those without prior irradiation history (p = 0.003). After 
logistic regression analysis, no component was confirmed as 
the risk factor for VCF. The 1-year fracture-free probability 
was 84.4%. The mean and median time to VCF after RT was 
6.7 months and 6.2 months, respectively (range, 5.1 to 8.9 
months). Univariate analysis confirmed the significance 
of prior irradiation history (p = 0.031), and pre-existing 
compression fracture (p < 0.001). Multivariate analysis also 
demonstrated that prior irradiation (HR, 33.34; 95% CI, 1.77–
630.48; p = 0.019) and pre-existing compression fractures (HR, 
23.13; 95% CI, 1.56–342.81; p = 0.022) were significant risk 
factors for VCF (Table 3). 
 Among the components of SINS criteria, vertebral body 
Table 1. Patient characteristics
Variable
No. of 
Segments 
(%) (n = 68)
No. of 
Patients 
(%) (n = 16)
Age (yr), median (range)
Sex
 Male
 Female
Pathology
 Adenocarcinoma
 Signet ring cell carcinoma
 Mucinous adenocarcinoma
 Neuroendocrine carcinoma
Body mass index (kg/m2)
 <30
 ≥30
Metastasis
 Present
 Absent
Spinal level
 Cervical
 Thoracic
 Lumbar
 Sacral
Prior irradiation
 Present
 Absent
Pre-existing fracture
 Present
 Absent
Total dose (Gy), median (range)
Fraction dose (Gy), median (range)
Total EQD2 (Gy)
 ≥32
 <32
Chemotherapy
 Yes
 No
60
33 (48.5)
35 (51.5)
43 (63.2)
5 (7.4)
8 (11.8)
12 (17.6)
60 (88.2)
8 (11.8)
42 (61.8)
26 (38.2)
5 (7.4)
24 (35.3)
27 (39.7)
12 (17.6)
10 (14.7)
58 (85.3)
4 (5.9)
64 (94.1)
30 
3 
53 (77.9)
15 (22.1)
40 (58.8)
28 (41.2)
(47–73)
7 (43.8)
9 (56.2)
11 (68.8)
1 (6.2)
1 (6.2)
3 (18.8)
14 (87.5)
2 (12.5)
-
-
-
-
-
-
-
-
-
-
(8–45)
(1.2–8.0)
-
-
9 (56.3)
7 (43.7)
EQD2, equivalent dose in 2 Gy per fraction.
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collapse (p = 0.003), SINS classification (p = 0.039) were 
identified as the significant predictive factors for VCF 
development in this study (Table 5). However, there was a 
trend towards more frequent fractures at the junctional spinal 
level than at other levels. Furthermore, spines with bilateral 
posterior element involvement showed more fractures than 
those with no involvement or unilateral posterior element 
involvement. Finally, SINS class showed statistical significance 
for an increased development of fractures in metastatic spines 
by univariate analysis (p = 0.002), but failed to show statistical 
significance in multivariate analysis (Table 3, Fig. 1D).
 Pain symptoms were reported in almost all of the patients 
that received palliative RT (14/16). After irradiation of these 14 
patients, pain reduction was reported in 12 patients (85.7%); 
consisted of 7 partial reductions (50.0%) and 5 complete 
reductions (35.7%). After development of VCF, fracture-induced 
pain was observed in five vertebral segments with a total of six 
VCFs and consisted of two cases of pain aggravation and three 
Table 2. Risk factors for vertebral compression fracture in all spines (n = 68)
Variable
No fracture
(n = 62 vertebral segments)
Fracture
(n = 6 vertebral segments)
Fractures (%) p-value
Age (yr)
 <60
 ≥60
Sex
 Male
 Female
Pathology
 Adenocarcinoma
 Signet ring cell carcinoma
 Mucinous adenocarcinoma
 Neuroendocrine carcinoma
Body mass index (kg/m2)
 <30
 ≥30
Metastasis
 Present
 Absent
Spinal Level
 Cervical
 Thoracic
 Lumbar
 Sacral
Prior irradiation
 Present
 Absent
Pre-existing fracture
 Present
 Absent
Total EQD2 (Gy)
 ≥32
 <32
Fraction dose (Gy)
 <3
 ≥3
Chemotherapy
 Yes
 No
28
34
31
31
38
5
7
12
54
8
37
25
5
22
25
10
7
55
1
61
50
12
6
56
37
25
5
1
2
4
5
0
1
0
6
0
5
1
0
2
2
2
3
3
3
3
3
3
2
4
3
3
15.2
2.9
6.1
11.4
11.6
0
12.5
0
10.0
0
11.9
3.8
0
8.3
7.4
16.7
30.0
5.2
75.0
4.7
5.7
20.0
25.0
6.7
7.5
10.7
0.101
0.674
0.485
0.601
0.395
0.780
0.037
0.002
0.116
0.143
0.684
EQD2, equivalent dose in 2 Gy per fraction.
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cases of development of new pain. In addition, two cases of 
spinal cord compression with weakness in both legs occurred 
and were successfully treated with decompressive surgery 
(Fig. 2, Table 6). There were 2 cases of tumor progression 
until the development of VCF among all spinal segments with 
fracture event, consisted of one metastatic spine and one 
non-metastatic spine. Vertebral segments with VCF events are 
summarized in Table 6.
Discussion and Conclusion
The present study identified the incidence and risk factors 
for VCF after conventional RT in homogenously characterized 
colorectal cancer patients, and clinical significances as 
described below. Because conventional RT still has a dominant 
role in palliative treatment for bone metastases, the results 
of our study will provide useful information for physicians. 
Moreover, although the use of bisphosphonate can delay or 
decrease development of VCF [2], our cohort contained only 
CRC patients who rarely use bisphosphonate. Furthermore, 
it was confirmed that bisphosphonate was not used in all 
patients. So we could identify the effect of RT on VCF without 
this confounding factor. The incidence of VCF in our study 
was 8.8%, suggesting that VCF after conventional RT is not 
particularly common. Additionally, we identified two risk 
factors for VCF, prior irradiation and pre-existing compression 
fracture. Therefore, timely management and close follow-up 
are required when planning to treat vertebral segments with 
these risk factors.
 Previous studies that focused on VCF after SBRT analyzed 
several risk factors including SINS criteria and revealed that 
lytic spinal lesion, spinal misalignment, pre-existing VCF, 
Fig. 1. Fracture-free probability (FFP) according to various risk factors. (A) Total irradiated spine. (B) With or without prior irradiation 
to total spine. (C) With or without pre-existing fracture in total spine. (D) FFP according to the Spinal Instability Neoplastic Score (SINS) 
class.
A
No prior irradiation (n = 58)
Prior irradiation (n = 10)
0 4 8 12
100
80
60
40
20
16
F
F
P
Time (months)
0
1-yr FFP 87.8%
0 4 8 12
100
80
60
40
20
16
F
F
P
Time (months)
0
p = 0.015
B
C
0 4 8 12
100
80
60
40
20
16
F
F
P
Time (months)
0
0 4 8 12
100
80
60
40
20
16
F
F
P
Time (months)
0
p = 0.002
D
p < 0.001
No pre-existing fx (n = 64)
Pr (n = 4)e-existing fx
SINS class I (n = 11)
SINS class II (n = 29)
SINS class III (n = 1)
Woo Joong Rhee, et al
226 www.e-roj.org http://dx.doi.org/10.3857/roj.2014.32.4.221
and vertebral body involvement increased the risk of VCF 
[9,10,12,13]. In this study, we identified prior irradiation and 
pre-existing compression fracture as risk factors for VCF, 
thus pre-existing compression fracture was a consistent risk 
factor among studies. However, prior irradiation was not 
identified as a risk factor in the studies of MDACC or the 
University of Toronto, although both studies evaluated the 
clinical significance of prior irradiation in VCF development. 
As the uncontrolled bone metastasis after RT can be the risk 
factor for VCF, the presence of prior irradiation history have 
the meaning of both severe radiation induced change and 
tumor progression even if prior RT. However, exact underlying 
mechanism of VCF is not well defined, and further research 
into this association is obviously necessary. 
 Recently, the SOSG introduced the SINS criteria to predict 
instability of the metastatic spine. Evaluation of their reliability 
and validity indicated that the sensitivity and specificity of 
these criteria in an unstable and potentially unstable group 
were 95.7% and 79.5%, respectively [14]. Although several 
groups have studied the relationship between SINS criteria and 
development of VCF after SBRT, whether SINS criteria can help 
predict VCF after conventional RT has not been validated. At 
our best knowledge, there is the only 1 published study that 
revealed the relationship between SINS criteria conventional 
RT [15]. They showed that a higher spinal instability score 
increased the risk of RT failure and retreatment, independent 
of performance status, primary tumor, and symptoms. Our 
study revealed that vertebral body collapse score could predict 
VCF after conventional RT, consistent with data from MSKCC. 
In addition, overall SINS class was significantly related with 
VCF (p = 0.002) in univariate analysis; however, the small 
number of vertebral body collapsed or class III spinal segments 
limited the statistical analysis. Further researches with large 
cases should be performed to confirm our results about the 
relation between conventional RT and SINS criteria.
 In contrast to SBRT, by defining target volume as the 
involved vertebral segment only, conventional fraction RT 
traditionally includes 1 to 2 levels of adjacent non-metastatic 
spines as well as all metastatic spines. Thus, it is important to 
know the risk and predictive factors for VCF in non-metastatic 
spines, and to date these factors have not been clearly defined. 
In our study, development of VCF after irradiation of non-
metastatic spine was observed only in one case (4%) among a 
total of 26 vertebral segments (case 6 of Table 6). Furthermore, 
not only the VCF development, but also tumor progression 
was observed in this case, suggesting that tumor progression 
is more reasonable cause for the development of VCF than 
radiation effect. Thus, there was no VCF on non-metastatic 
vertebral segment without tumor involvement in our study 
cohort, suggesting the inclusion of adjacent metastasis-free 
Table 3. Significant risk factors for vertebral compression fracture in univariate and multivariate analysis
Variable
Univariate Multivariate
1-yr FFP p-value HR 95% CI p-value
All spines
Prior irradiation
 Present
 Absent
Pre-existing fracture
 Present
 Absent
92.5
66.7
93.7
25.0
0.015
<0.001
7.304
18.445
1.306–40.856
3.419–99.520
0.024
0.001
Metastatic spines
Prior irradiation
 Present
 Absent
Pre-existing fracture
 Present
 Absent
SINS classification
 Class I
 Class II
 Class III
90.9
64.8
92.9
25.0
100
81.6
0.0
0.031
<0.001
0.002
33.337
23.129
NA
1.767–630.476
1.560–342.807
NA
0.019
0.022
0.340
FFP, fracture-free probability; HR, hazard ratio; CI, confidence interval; NA, not applicable; SINS, Spine Instability Neoplastic Score.
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vertebra seems to be safe. On the other hand, after irradiation 
of metastatic spine, VCF was observed in five cases (12%) 
among a total of 42 vertebral segments, suggesting that 
irradiation of the metastatic spine is somewhat riskier. One 
possible cause of VCF is weakening of the bone structure 
induced by radiation. Al-Omair et al. [16] investigated the 
pathophysiology of VCF development after SBRT by spine 
tissue biopsy and revealed that radiation-induced necrosis and 
fibrosis contributed to VCF development after SBRT with a high 
fractional dose. However, the fractional dose in conventional 
RT is much lower than that of SBRT, suggesting the possibility 
of another mechanism related to VCF after conventional RT, 
other than tumor regression. However the exact mechanism is 
currently unclear and our study did not identify any risk factor 
for VCF in non-metastatic spines. 
 We reviewed all cases of VCF in this study and found six 
fractured vertebral segments. Among these, pain aggravation 
was observed in five cases, and spinal cord compression 
Table 4. Risk factors for vertebral compression fracture in metastatic spine (n = 42)
Variable
No fracture
(n = 37 vertebral segments)
Fracture
(n = 5 vertebral segments)
Fractures (%) p-value
Age (yr)
 <60
 ≥60
Sex
 Male
 Female
Pathology
 Adenocarcinoma
 Signet ring cell carcinoma
 Mucinous adenocarcinoma
 Neuroendocrine carcinoma
Body mass index (kg/m2)
 <30
 ≥30
Para-spinal extension
 Present
 Absent
Spinal Level
 Cervical
 Thoracic
 Lumbar
 Sacral
Prior irradiation
 Present
 Absent
Pre-existing fracture
 Present
 Absent
Total EQD2 (Gy)
 ≥32
 <32
Fraction dose
 <3
 ≥3
Chemotherapy
 Yes
 No
 
20
17
 
23
14
 
15
5
7
10
 
31
6
 
4
33
 
2
9
17
9
 
6
31
 
1
36
 
30
7
 
2
35
 
19
18
 
5
0
 
2
3
 
4
0
1
0
 
5
0
 
2
3
 
0
1
2
2
 
3
2
 
3
2
 
3
2
 
1
4
 
2
3
 
20.0
0
 
8.0
17.6
 
21.1
0
12.5
0
  
13.9
0
 
33.3
8.3
 
0
10.0
10.5
18.2
 
33.3
6.1
 
75.0
5.3
 
9.1
22.2
 
33.3
10.3
 
9.5
14.3
0.070
0.632
0.327
0.585
0.875
0.057
0.003
0.141
0.567
0.323
1
EQD2, equivalent dose in 2 Gy per fraction.
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presenting with weakness in both legs was observed in 
two cases (case 1, 6), especially for case 6, there was newly 
developed tumor involvement in non-metastatic spine. 
Decompressive laminectomy and tumor removal were 
successfully performed. A prophylactic stabilizing procedure 
(e.g., vertebroplasty) should be considered when the targeted 
vertebral segment has risk factors for VCF, because VCF can 
cause pain and neurologic symptoms. In addition, regular 
interval imaging and clinical follow-up is needed to inspect for 
the development of VCF.
 Special consideration is needed when interpreting the 
results of this study because of the inherent limitations of 
a retrospective study. In spite of our best efforts to perform 
regular follow-up imaging studies with uniform modalities 
there were some inconsistencies in imaging modality and 
follow-up interval among patients. Therefore, the incidence 
of VCF might be underestimated because of incomplete 
assessment. As a result of the exclusion criteria, only 68 
vertebral segments of 16 patients were included in our study, 
limiting our statistical power to analyze prognostic factors. 
However, most patients in our study cohort might be relatively 
long-term survivors, suggesting that our results address a 
clinically relevant problem after palliative RT. As our study did 
not focus on event per patient but rather event per vertebral 
segment, the reliability of data on the patients’ characteristics 
could be diminished in cases of multiple fractures in one 
patient. However, we found six fractures in five patients in this 
study, indicating only a single case of multiple fractures, thus 
the reliability of this study is not significantly compromised. 
Conversely, our study revealed that the presence of a risk 
Table 5. SINS criteria in metastatic spine (n = 42)
Variable
No fracture
(n = 37 vertebral segments)
Fracture
(n = 5 vertebral segments)
Fractures 
(%)
p-value
Location
 Rigid (S2–S5)
 Semi-rigid (T3–T10)
 Mobile spine (C3–C6, L2–L4)
 Junctional (occiput–C2, C7–T2, T11–L1, L5–S1)
Pain
 Pain free
 Occasional and non-mechanical
 Mechanical
Bone lesion type
 Blastic
 Mixed
 Lytic
Alignment
 Normal
 Kyphosis/scoliosis
 Subluxation/translation
Vertebral body collapse
 ≥50%
 <50%
 No collapse, but tumor involvement in >50% of body 
 None of the above
Posterior element
 Not involved
 Unilateral
 Bilateral
SINS classification
 Class I
 Class II
 Class III
 
6
4
13
14
 
2
5
30
 
0
16
21
 
34
3
0
 
1
0
9
27
 
25
4
8
 
11
25
0
 
0
0
0
5
 
0
1
4
 
0
1
4
 
5
0
0
 
0
2
2
1
 
1
1
3
 
0
4
1
 
0
0
0
26.3
 
0
16.7
11.8
 
0
5.9
16.0
 
12.8
0
0
 
0
100
18.2
3.6
 
3.8
20.0
27.3
 
0
13.8
100
0.081
1
0.392
1
0.003
0.095
0.039
C, cervical spine; T, thoracic spine; L, lumbar spine; S, sacrum; SINS, Spine Instability Neoplastic Score.
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factor in a certain vertebral segment does not increase the 
fracture risk at other spinal levels.
 Overall, the incidence of VCF after conventional RT is 
not very high. However, close observation is warranted 
in patients with prior irradiation to the spine and/or pre-
existing compression fracture in the spine. In addition, SINS 
criteria can be used as an option for predicting fracture 
risk before performing conventional RT. Further studies are 
required to confirm these findings and examine the validity of 
extrapolating our results to bone metastasis in the setting of 
other tumors. 
Fig. 2. (A) A newly developed ver-
tebral compression fracture (VCF) 
in the T3 vertebral segment at 4.9 
months after irradiation with 25 
Gy in 10 fractions. There were no 
meta static lesions, prior irradi-
ation, or pre-existing fractures 
before radiation therapy. Upper 
back pain and weakness in both 
legs were observed after VCF and 
were successfully treated by de-
com pressive laminectomy (case 6 
in Table 6). (B) VCF progression was 
observed in the L5 vertebral segment 
at 8.9 months after irradiation with 
30 Gy in 10 fractions. This ver tebral 
segment had a metastatic lesion 
and pre-existing fracture. Lower 
back pain and weakness in both legs 
were observed after VCF and were 
successfully treated by de compressive 
laminectomy (case 1 in Table 6).
A
B
Table 6. Summary of vertebral segments with vertebral compression fracture events
Variable Case 1 Case 2a) Case 3a) Case 4 Case 5 Case 6
Spine level
Metastasis
Prior irradiation
Pre-existing fracture
SINS classification
Total dose/fractions
Tumor progression
RT-Fx. time (month)
Associated symptom
Treatment
L5
Present
Absent
Present
Class II
30 Gy/10 fx
No
8.9
LBP, 
Both leg 
weakness
Decompressive 
laminectomy
L5
Present
Present
Absent
Class II
30 Gy/10 fx
No
5.1
LBP
Pain medication
S1
Present
Present
Present
Class II
30 Gy/10 fx
No
5.1
LBP
Pain medication
T12
Present
Absent
Present
Class III
8 Gy/1 fx
No
6.2
None
None (close f/u)
S1
Present
Present
Absent
Class II
30 Gy/25 fx
Yes
8.2
LBP
Pain medication
T3
Absent
Absent
Absent
-
25 Gy/10 fx
Yesb)
4.9
UBP, 
Both leg 
weakness
Decompressive 
laminectomy
T, thoracic spine; L, lumbar spine; S, sacrum; SINS, Spine Instability Neoplastic Score; fx, fractions; RT-Fx. time, monthly time interval be-
tween start date of radiation therapy and fracture event; LBP, lower back pain; UBP, upper back pain; f/u, follow-up.
a)Case 2 and case 3 were different vertebral segments from the same patient. b)Newly developed spine metastasis was observed in case 6.
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